News Agency
Men's Weekly

Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer

  • Written by PR Newswire
Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer

Highlights

  • FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer 
  • Phase III trial design based on 64Cu SAR-bisPSMA data package, including positive results from the completed PROPELLER trial
  • A total of 383 prostate cancer patients to take part in a pivotal, non-randomised, single-arm,...

Read more: Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer

Defense Industry Jobs and Defence Recruitment: Building Careers That Shape National Security

The defence sector is one of the most important contributors to national security, innovation, and economic growth. Across Australia and worldwide, defense industry jobs offer opportunities for individuals to work in fields that combine technology, strategy, and service to the nation... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion